Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Spectral Diagnostics Inc.
Disease management company announces terms of proposed private share placement
December 7th, 2004
Spectral Diagnostics Inc. (SDI), announced the terms of its previously announced proposed private placement. Pursuant to the terms of an amended engagement letter, it is proposed that McFarlane Gordon, Paradigm Capital and Loewen Ondaatje, McCutcheon, will sell, as agents on a best efforts basis, 2,713,136 units of the corporation at a price of $1.35 per unit for proposed gross proceeds of $3,662,733.60. Each unit would consist of 1 common share in the capital of the corporation and one-half of 1 common share purchase warrant. Each whole common share purchase warrant would entitle the holder to acquire one common share, at a price of $1.55 per share,...
Source: Cardiovascular Business Week (2004-12-07)
|
